Maša Bošnjak

1.3k citations
59 papers · 960 indexed · h-index 21
Topics
Microbial Inactivation Methods (44 papers)Microfluidic and Bio-sensing Technologies (18 papers)CRISPR and Genetic Engineering (10 papers)

In The Last Decade

Maša Bošnjak

58 papers receiving 951 citations

Peers

Maša Bošnjak
Comparison fields: 5 of 82
  • Biotechnology 685
  • Biomedical Engineering 371
  • Molecular Biology 302
  • Immunology 264
  • Oncology 106
Replace John O. Larkin with:
John O. Larkin Ireland
Aleš Grošelj Slovenia
Anita Gothelf Denmark
Tobian Muir United Kingdom
Joy Odili United Kingdom
Urša Lampreht Tratar Slovenia
Darja Pavlin Slovenia
Gaëlle Le'Negrate France
Erika Kis Hungary
Hyun Taek Park South Korea
Maša Bošnjak relative to John O. Larkin Ireland John O. Larkin's profile →
Citations per field
00.5×3.8×
John O. Larkin · 1×
Citations per year

Countries citing papers authored by Maša Bošnjak

Since Specialization
Citations

This map shows the geographic impact of Maša Bošnjak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maša Bošnjak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maša Bošnjak more than expected).

Fields of papers citing papers by Maša Bošnjak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maša Bošnjak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maša Bošnjak. The network helps show where Maša Bošnjak may publish in the future.

Co-authorship network of co-authors of Maša Bošnjak

This figure shows the co-authorship network connecting the top 25 collaborators of Maša Bošnjak. A scholar is included among the top collaborators of Maša Bošnjak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maša Bošnjak. Maša Bošnjak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 5
3 6
4 4
5 20
6 7
7 5
8 41
9 12
10 33
11 29
12 4
13 2
14 6
15 18
16 21
17 68
18 33
19 20
20 14

About Maša Bošnjak

Maša Bošnjak is a scholar working on Biotechnology, Biomedical Engineering and Immunology, having authored 59 papers that have together received 960 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (44 papers), Microfluidic and Bio-sensing Technologies (18 papers) and CRISPR and Genetic Engineering (10 papers). The work is most often cited by research in Biotechnology (685 citations), Immunology (264 citations) and Biomedical Engineering (371 citations). Maša Bošnjak has collaborated with scholars based in Slovenia, United States and United Kingdom. Frequent co-authors include Maja Čemažar, Gregor Serša, Loreé C. Heller, Aleš Grošelj, Boštjan Markelc, Damijan Miklavčič, Bor Kos, Simona Kranjc, Mojca Kržan and Tanja Jesenko. Their work appears in journals such as Nucleic Acids Research, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026